
Cocrystal Pharma COCP
€ 0.89
0.0%
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Cocrystal Pharma DPO 2011-2026 | COCP
DPO Jährlich Cocrystal Pharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 27 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 27 | 27 | 27 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Regeneron Pharmaceuticals
REGN
|
195 | $ 742.1 | -1.93 % | $ 77.6 B | ||
|
AbbVie
ABBV
|
65.5 | $ 211.9 | 0.37 % | $ 375 B | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Rigel Pharmaceuticals
RIGL
|
97.9 | $ 26.28 | -0.34 % | $ 473 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
246 | $ 77.56 | -5.31 % | $ 5.04 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Avid Bioservices
CDMO
|
62.3 | - | - | $ 789 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
35.1 | $ 12.27 | -12.11 % | $ 1.86 B | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
SIGA Technologies
SIGA
|
13.3 | $ 5.36 | 7.96 % | $ 383 M | ||
|
Silence Therapeutics plc
SLN
|
10.6 | $ 4.92 | -7.34 % | $ 622 M | ||
|
SELLAS Life Sciences Group
SLS
|
10 K | $ 4.47 | -9.69 % | $ 487 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
193 | $ 1.08 | -1.38 % | $ 22.2 M | ||
|
Summit Therapeutics
SMMT
|
84.9 K | $ 16.59 | -3.88 % | $ 12.4 B |